IF 3.2 3区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS
Jingyi Xiao, Zan Ge, Xiaowei Tan, Ziyi Liu, Yafang Zhang, Shufen Xiao, Rongyuan Yi, Ye Hu, Wenyan Hu, Hui Chu, Jian Chen
{"title":"Biodegradable Covalent Beta-Cyclodextrin Nanocages for Acidic and Reductive-Responsive Drug Delivery in Enhanced Tumor Therapy","authors":"Jingyi Xiao,&nbsp;Zan Ge,&nbsp;Xiaowei Tan,&nbsp;Ziyi Liu,&nbsp;Yafang Zhang,&nbsp;Shufen Xiao,&nbsp;Rongyuan Yi,&nbsp;Ye Hu,&nbsp;Wenyan Hu,&nbsp;Hui Chu,&nbsp;Jian Chen","doi":"10.1002/biot.70006","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Traditional beta-cyclodextrin (beta-CD) in biomedical applications faces challenges due to its inherent physical and biochemical limitations. One of the most effective strategies to enhance the properties of beta-CD for drug delivery is the synthesis of supramolecular polycyclodextrins. In this study, we designed a novel beta-CD nanocage-like structure for drug delivery, incorporating imine and disulfide bonds through Schiff base reactions. Aldehyde group-functionalized beta-CD units were used to construct the main backbone of the nanocage, forming dual-dynamic covalent bonds. The chemical structure of the beta-CD nanocage was confirmed using ¹H nuclear magnetic resonance (¹H NMR) and Fourier transform infrared spectroscopy (FTIR). Additionally, atomic force microscopy (AFM) and dynamic light scattering (DLS) revealed that varying amounts of beta-CD crosslinked with cystamine resulted in nanocages approximately 200 nm in size. In vitro drug release experiments demonstrated that doxorubicin (DOX)-loaded beta-CD nanocages exhibited accelerated DOX release in acidic and reductive environments compared to normal physiological conditions, owing to the pH-sensitive imine bond and the glutathione (GSH)-cleavable disulfide bond. The DOX-loaded beta-CD nanocages showed exceptional tumor-killing effects, particularly in acid/reduction-enhanced tumor cells. Both cellular fluorescence imaging and flow cytometry confirmed the potential of the beta-CD nanocages for acid/reduction-specific drug release. Consequently, this precision medicine model using imine/disulfide-linked beta-CD nanocage structures as acidity/reduction-sensitive drug carriers promises to improve oncotherapy through more targeted drug delivery and release, supporting individualized treatment approaches.</p>\n </div>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"20 3","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/biot.70006","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

摘要

由于其固有的物理和生物化学局限性,传统的β-环糊精(β-CD)在生物医学应用中面临着挑战。增强 beta-CD 药物递送性能的最有效策略之一是合成超分子聚环糊精。在本研究中,我们设计了一种新型的β-CD纳米囊状结构,通过希夫碱反应结合亚胺键和二硫键,用于药物递送。醛基官能化的β-CD单元被用来构建纳米笼的主骨架,形成双动力共价键。¹H核磁共振(¹H NMR)和傅立叶变换红外光谱(FTIR)证实了β-CD纳米笼的化学结构。此外,原子力显微镜(AFM)和动态光散射(DLS)显示,不同量的β-CD与胱胺(cystamine)交联可形成大小约为200纳米的纳米囊。体外药物释放实验表明,与正常生理条件相比,由于对 pH 值敏感的亚胺键和可被谷胱甘肽(GSH)分解的二硫键,负载 DOX 的 beta-CD 纳米囊在酸性和还原性环境中表现出更快的 DOX 释放速度。装载了 DOX 的 beta-CD 纳米笼显示出卓越的肿瘤杀伤效果,尤其是在酸性/还原性增强的肿瘤细胞中。细胞荧光成像和流式细胞术都证实了β-CD纳米包具有酸/还原特异性药物释放的潜力。因此,这种使用亚胺/二硫化物连接的β-CD纳米载体结构作为酸性/还原敏感性药物载体的精准医疗模式有望通过更有针对性的药物输送和释放改善肿瘤治疗,支持个体化治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Biodegradable Covalent Beta-Cyclodextrin Nanocages for Acidic and Reductive-Responsive Drug Delivery in Enhanced Tumor Therapy

Biodegradable Covalent Beta-Cyclodextrin Nanocages for Acidic and Reductive-Responsive Drug Delivery in Enhanced Tumor Therapy

Traditional beta-cyclodextrin (beta-CD) in biomedical applications faces challenges due to its inherent physical and biochemical limitations. One of the most effective strategies to enhance the properties of beta-CD for drug delivery is the synthesis of supramolecular polycyclodextrins. In this study, we designed a novel beta-CD nanocage-like structure for drug delivery, incorporating imine and disulfide bonds through Schiff base reactions. Aldehyde group-functionalized beta-CD units were used to construct the main backbone of the nanocage, forming dual-dynamic covalent bonds. The chemical structure of the beta-CD nanocage was confirmed using ¹H nuclear magnetic resonance (¹H NMR) and Fourier transform infrared spectroscopy (FTIR). Additionally, atomic force microscopy (AFM) and dynamic light scattering (DLS) revealed that varying amounts of beta-CD crosslinked with cystamine resulted in nanocages approximately 200 nm in size. In vitro drug release experiments demonstrated that doxorubicin (DOX)-loaded beta-CD nanocages exhibited accelerated DOX release in acidic and reductive environments compared to normal physiological conditions, owing to the pH-sensitive imine bond and the glutathione (GSH)-cleavable disulfide bond. The DOX-loaded beta-CD nanocages showed exceptional tumor-killing effects, particularly in acid/reduction-enhanced tumor cells. Both cellular fluorescence imaging and flow cytometry confirmed the potential of the beta-CD nanocages for acid/reduction-specific drug release. Consequently, this precision medicine model using imine/disulfide-linked beta-CD nanocage structures as acidity/reduction-sensitive drug carriers promises to improve oncotherapy through more targeted drug delivery and release, supporting individualized treatment approaches.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Biotechnology Journal
Biotechnology Journal Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍: Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances. In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office. BTJ promotes a special emphasis on: Systems Biotechnology Synthetic Biology and Metabolic Engineering Nanobiotechnology and Biomaterials Tissue engineering, Regenerative Medicine and Stem cells Gene Editing, Gene therapy and Immunotherapy Omics technologies Industrial Biotechnology, Biopharmaceuticals and Biocatalysis Bioprocess engineering and Downstream processing Plant Biotechnology Biosafety, Biotech Ethics, Science Communication Methods and Advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信